The first nanofluidic based immunoassay platform
Demonstrating Industry excellence with point of care rapid asthma & allergy diagnosis
Current allergy testing systems do not allow professionals to have immediate and quantitative results at the point of care.
Patients have to wait a very long time to obtain laboratory quantitative results, while they must provide larger blood samples for testing. Alternatively, there is a range of rapid testing options, but they don’t offer test customization options and they only present qualitative results that are often not accurate.
The abioSCOPE® is set to revolutionize allergy testing by addressing the current diagnostic obstacles and restrictions.
Our solution provides a complete, customizable and fully reliable IgE allergy diagnosis. With the abioSCOPE®, the interval between screening process and obtaining results is drastically reduced from many days or weeks to less than one hour, directly at your most trusted healthcare professional.